Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Apr. 19];4(6):s94. Available from: https://skin.dermsquared.com/skin/article/view/1064